journal article·2022-12

Regulation of Synovial Macrophages Polarization by Mimicking Efferocytosis for Therapy of Osteoarthritis

Hongbin Yang, Zhenyan Yu, Shuaishuai Ji, Jie Yan, Yan kong, Qiang Huo, Zhijun Zhang, Yimin Niu, Yang Liu

Advanced Functional Materials· Volume 32· Issue 52
Publisher page

Abstract

Abstract The progression of osteoarthritis is associated with chronic synovitis caused by synovial macrophage infiltration and proinflammatory M1 polarization. Accordingly, repolarization of macrophages from the M1 to M2 phenotype by nanoagents is proposed as a potential treatment strategy. However, achieving adequate effects using intra‐articular injected agents is challenging due to the rapid drug clearance from the joint space and poor efficiency of nanoparticles endocytosis by synovial macrophage cells. Herein, apoptotic chondrocyte membrane‐coated, quercetin‐loaded metal‐organic framework nanoparticles as immunomodulators for treating osteoarthritis are reported. The apoptotic chondrocyte membrane‐camouflaged nanoparticles containing various natural “eat me” signals can be easily disguised as chondrocyte apoptotic bodies in the joints, and thus are more easily phagocytized by synovial macrophages similarly to efferocytosis. Furthermore, the released quercetin promotes the polarization of synovial macrophages to the M2 phenotype and also inhibites the apoptosis of articular chondrocytes. In vivo results suggest that such a “Trojan horse” strategy can extend the retention time of nanoparticles in osteoarthritis joints and improve treatment efficacy. Collectively, it is hoped that this study can offer a potential and universal platform for engineered cell membrane‐coated nanoparticles to resolve inflammation by simulating specific inflammatory processes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Phagocytosis and Immune Regulation · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurology Affliated Zhongda Hospital School of Medicine Institution of Neuropsychiatry Southeast University Nanjing Jiangsu 210009 China

Department of Pharmaceutics School of Pharmacy Nanjing Medical University Nanjing Jiangsu 211166 China

Department of Pharmacy Affliated Zhongda Hospital School of Medicine Southeast University Nanjing Jiangsu 210009 China

School of Pharmacy Bengbu Medical College Bengbu Anhui 233030 China

Department of Mental Health and Public Health Faculty of Life and Health Sciences Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen Guangdong 518055 China

Key Laboratory of Cardiovascular and Cerebrovascular Medicine School of Pharmacy Nanjing Medical University Nanjing Jiangsu 211166 China

Funding

National Natural Science Foundation of China

References (55)

Show source-provided references
1. Long H. · Arthritis Rheumatol. · 2022 · 30 · 196
2. 10.1038/s41584-020-0447-810.1038/s41584-020-0447-8 ↗
3. 10.1038/s41584-018-0123-410.1038/s41584-018-0123-4 ↗
4. 10.1016/j.joca.2021.10.00310.1016/j.joca.2021.10.003 ↗
5. 10.1016/j.joca.2020.01.00710.1016/j.joca.2020.01.007 ↗
6. 10.1136/annrheumdis-2018-21345010.1136/annrheumdis-2018-213450 ↗
7. 10.1016/j.cytogfr.2019.03.00410.1016/j.cytogfr.2019.03.004 ↗
8. 10.1038/s41584-022-00749-910.1038/s41584-022-00749-9 ↗
9. 10.1126/sciadv.abd051510.1126/sciadv.abd0515 ↗
10. 10.1038/s41586-019-1471-110.1038/s41586-019-1471-1 ↗
11. 10.1369/002215541774088010.1369/0022155417740880 ↗
12. 10.1038/s41467-020-18208-y10.1038/s41467-020-18208-y ↗
13. 10.3389/fmed.2020.60718610.3389/fmed.2020.607186 ↗
14. 10.1186/s13075-017-1229-910.1186/s13075-017-1229-9 ↗
15. 10.1016/j.jconrel.2022.04.03710.1016/j.jconrel.2022.04.037 ↗
16. 10.1016/j.biomaterials.2021.12086510.1016/j.biomaterials.2021.120865 ↗
17. 10.1002/adma.20220271510.1002/adma.202202715 ↗
18. 10.1002/adma.20200417210.1002/adma.202004172 ↗
19. 10.1002/adfm.20210340910.1002/adfm.202103409 ↗
20. 10.1002/adfm.20210092410.1002/adfm.202100924 ↗
21. 10.1021/acsami.9b1632710.1021/acsami.9b16327 ↗
22. 10.1002/smsc.20210011610.1002/smsc.202100116 ↗
23. 10.1016/j.actbio.2020.03.04110.1016/j.actbio.2020.03.041 ↗
24. 10.1038/nrc317110.1038/nrc3171 ↗
25. 10.3389/fcimb.2017.0019110.3389/fcimb.2017.00191 ↗
26. 10.1084/jem.2016137510.1084/jem.20161375 ↗
27. 10.1038/nature1537310.1038/nature15373 ↗
28. 10.1016/j.jconrel.2022.04.01910.1016/j.jconrel.2022.04.019 ↗
29. 10.1016/j.addr.2020.05.00510.1016/j.addr.2020.05.005 ↗
30. 10.1002/adfm.20160143010.1002/adfm.201601430 ↗
31. 10.1002/advs.20210046010.1002/advs.202100460 ↗
32. 10.1002/advs.20210233010.1002/advs.202102330 ↗
33. 10.1038/s41580-020-0232-110.1038/s41580-020-0232-1 ↗
34. 10.1038/s41577-019-0240-610.1038/s41577-019-0240-6 ↗
35. 10.1002/jev2.1210910.1002/jev2.12109 ↗
36. 10.1016/j.freeradbiomed.2019.09.02410.1016/j.freeradbiomed.2019.09.024 ↗
37. 10.1016/j.bcp.2006.08.00110.1016/j.bcp.2006.08.001 ↗
38. 10.2174/156652402166621031512533010.2174/1566524021666210315125330 ↗
39. 10.3389/fimmu.2017.0090910.3389/fimmu.2017.00909 ↗
40. 10.1016/j.jconrel.2021.11.00510.1016/j.jconrel.2021.11.005 ↗
41. 10.1016/j.biomaterials.2019.11957910.1016/j.biomaterials.2019.119579 ↗
42. 10.5435/00124635-200311000-0000610.5435/00124635-200311000-00006 ↗
43. 10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗
44. 10.7150/thno.4784110.7150/thno.47841 ↗
45. 10.1002/ange.20211367110.1002/ange.202113671 ↗
46. 10.1002/jbm.b.3379310.1002/jbm.b.33793 ↗
47. 10.1002/art.178009010610.1002/art.1780090106 ↗
48. 10.1126/scitranslmed.aat880010.1126/scitranslmed.aat8800 ↗
49. 10.1038/nrrheum.2013.15910.1038/nrrheum.2013.159 ↗
50. 10.1016/S1534-5807(03)00090-X10.1016/S1534-5807(03)00090-X ↗
51. 10.1038/nri221410.1038/nri2214 ↗
52. 10.3389/fonc.2019.0041110.3389/fonc.2019.00411 ↗
53. 10.1371/journal.pone.012699310.1371/journal.pone.0126993 ↗
54. 10.1038/nprot.2008.9510.1038/nprot.2008.95 ↗
55. 10.1126/sciadv.aba298710.1126/sciadv.aba2987 ↗